ACT Genomics and Sanomics Merge to Unleash Hong Kong's Global Potential in Healthcare Technology
Asia-based next-generation oncology diagnostic powerhouse to take on global market with total solutions to patients, medical professionals, pharmaceutical companies, and research institutes HONG KONG, Nov 22, 2021 - (ACN Newswire) - ACT Genomics Holdings Co. Ltd. ("ACT Genomics" or "the Group") a leading cancer solution provider in Asia, announced today that it has merged with Sanomics Holdings Limited ("Sanomics"), a champion in lung cancer diagnostics in Hong Kong and Thailand. Both ACT Genomics and Sanomics are park companies of Hong Kong Science and Technology Parks Corporation (HKSTP) and...